Genekam to attend BIO CEO & Investor Conference
February 26-27, 2024 | New York
Genekam registered with EUDAMED - A step towards meeting the latest IVDR requirements!
|Name of ready to use
|SUD7||Genekam P Immune V:Ready to use kit for in vitro primary immunisation of human B-lymphocytes of peripheral blood against viral targets||call|